京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第22366号 / 医博第4607号 / 新制||医||1043(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 林 康紀, 教授 岩田 想, 教授 高橋 淳 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM

In Sweden spent nuclear fuel is planned to be placed 500 m down in the bedrock. The spent nuclear fuel will be contained in copper canisters. The reason behind the selection of copper is its thermodynamic stability against corrosion in the depository. The copper will be exposed to mechanical loading and will be plastically deformed due to creep. The canisters will be sealed by friction stir welding. Since the canisters have to survive intact for many thousands of years, the properties of the welds are critical. Oxygen free P-doped copper (Cu-OFP) is selected for its excellent creep ductility properties and corrosion resistance. In this thesis work creep ductility behavior of friction stir welded copper chosen at different areas of the weld is evaluated by using the test slow strain rate tensile test. Samples are chosen at different weld areas namely weld, cross weld and HAZ. A sum of 21 specimens is tested. These tests are achieved at three various strain rates and each rate are carried out at three different temperatures. The strain rates used for tests are 1e-4, 3e-6 and 1e-7 [1/s]. The samples are strained until rupture, 20% and 5% of the gauge length. Yield strength and tensile strength are usually decreasing with increasing temperature and at higher temperature the material can be easily deformed. Few strange behaviors are also observed for the samples from HAZ areas at strain rate 1e-7[1/s]. The experimental results are justified by using the Knock-Mecking model. The parametersand ω were evaluated by curve fitting method.

New genome-editing approaches, such as the CRISPR/Cas system, have opened up great opportunities to insert or delete genes at targeted loci and have revolutionized genetics in model organisms like the zebrafish. The Cre-loxp recombination system is widely used to activate or inactivate genes with high spatial and temporal specificity. Using a CRISPR/Cas9-mediated knock-in strategy, we inserted a zebrafish codon-optimized CreERT2 transgene at the otx2 gene locus to generate a conditional Cre-driver line.We chose otx2 as it is a patterning gene of the anterior neural plate that is expressed during early development. By knocking in CreERT2 upstream of the endogenous ATG of otx2, we utilized this gene’s native promoter and enhancer elements to perfectly match CreERT2 and endogenous otx2 expression patterns. Next, by combining this novel driver line with a Cre-dependent reporter line, we show that only in the presence of tamoxifen can efficient Cre-loxp-mediated recombination be achieved in the anterior neural plate-derived tissues like the telencephalon, the eye and the optic tectum. Our results imply that the otx2:CreERT2 transgenic fish will be a valuable tool for lineage tracing and conditional mutant studies in larval and adult zebrafish.

Genome editing is an exciting field that allows for the precise modification of an organism's DNA. One of the most advanced tools in this area is CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9), which creates a DSB (Double-strand break) at a specific location in the genome. This break can then be repaired by the cell using one of two pathways – NHEJ (nonhomologous end joining) or HDR (homology-directed repair) HDR leads to more precise repair and is used to create KI (Knock-In) modifications by introducing a homologous piece of DNA with the desired changes. However, HDR is a rare event that competes with the error prone NHEJ pathway, limiting its efficiency. HDR mainly occurs in the G2 and S phases of the cell cycle, making it a challenge to control and target. To improve KI efficiency, researchers have used strategies such as inhibiting NHEJ or activating HDR. This study focuses on identifying direct and indirect activators of HDR through a library assay screening. We established a robust method for screening compounds in HEK293 cells that relies on a plasmid-based delivery Cas9, gRNA (guide RNA), and synthetic ssDNA (single strand DNA). Out of 3,000 compounds screened, 1% showed a higher signal than the positive control, and approximately 10% presented a higher signal than untreated cells. The top 5 compounds were further validated in dose response. Our system opens new avenues for improving the efficiency of KI modifications.

No description available.

No description available.

Background Multiple myeloma is an incurable cancer disease that emerges from the bone marrow. Bone morphogenetic proteins (BMPs) are ligands that activates intracellular signaling pathways causing activation of transcription factors. Previous studies show that BMP treatment of myeloma cells induce apoptosis, a mechanism dependent on downregulation of c-MYC. BMPs uses different receptors on myeloma cells, but it is still unclear how the intracellular signaling pathway leading to apoptosis works. A recent whole genome CRISPR/Cas9 knockout screening suggested FOXO1 as a gene involved in the mechanism of apoptosis during BMP treatment. We therefore aimed to investigate further on how FOXO1 has an impact on BMP induced apoptosis. Methods Our hypothesis was that knockout of FOXO1 would protect the cells from apoptosis. To begin to address this issue we tested INA-6 FOXO1 knock-out cell clones that was generated before the start of the project and treated them with BMP-9 to look for effects on cell viability and protein expression. We measured cell viability using CellTiter-Glo® 2.0 Cell viability assay and expression of c-MYC and FOXO1 protein using Western blot. Results and conclusions Treatment with BMP-9 for 72 hours showed a decrease in viability of the cells, up to 98%. Protein expression of c-MYC was inhibited by BMP-9 treatment while a constant expression of FOXO1 was seen in all cells clones regardless of BMP treatment. Expression of FOXO1 in the FOXO1 knock-out cells indicates that the knock-out has not worked. More experiments are needed to clarify the role of FOXO1 in BMP-induced apoptosis.

No description available.

Le syndrome des Néoplasies Endocriniennes Multiples de type 1 (NEM1) est une maladie à transmission autosomique dominante liée à l’inactivation du gène MEN1. Le but de mon travail de thèse était d’étudier le rôle biologique et oncosuppressif du gène Men1 dans le pancréas endocrine. La caractérisation d’un nouveau modèle m’a permis de démontrer que l’invalidation du gène Men1 spécifiquement dans les cellules alpha conduit à la fois au développement de glucagonomes et d’insulinomes par un mécanisme de transdifférenciation de cellules exprimant le glucagon en cellules exprimant l’insuline. Parallèlement, en explorant les modèles murins où le gène Men1 est invalidé respectivement dans les cellules alpha et beta Pancréatiques, j’ai pu identifier l’expression altérée de certains facteurs de transcription ayant des fonctions vitales dans ces cellules, notamment Foxa2 et MafB, dans les lésions précoces des cellules endocrines pancréatiques correspondantes. En conclusion, mon travail de thèse a permis de mieux clarifier la fonction biologique du gène Men1 dans les cellules pancréatiques endocrines et de mieux comprendre les mécanismes impliqués dans la survenue du syndrome MEN1 / Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant inherited syndrome caused by mutations of the MEN1 gene. The aim of my work is to investigate the biological and oncosuppressive roles of the Men1 gene in the pancreatic endocrine cells. The analyses carried out in a new mouse model showed that Men1 ablation in alpha cells trigged the development of both glucagonoma and insulinoma by the transdifferentiation from glucagon-producing cells to insulin-expressing cells. Furthermore, the data obtained from the characterization of both alpha- and beta-cell-specific Men1 mutant mice allowed to identify the altered expression of several important endocrine specific transcriptional factors, including Foxa2 and MafB, found in the early lesions of the corresponding pancreatic endocrine cells. Overall, my thesis work provides interesting clues for better understanding the mechanisms involved in the tumorigenesis of MEN1 syndrome

The immune system is essential for keeping the integrity of multicellular organisms. We were able to make a step forward in studying the complex immune reactions in mammals in vivo and/ or in situ using the major histocompatibility complex (MHC) class II/ enhanced green fluorescent protein (EGFP) knock-in mouse model. Due to the EGFP visualization of MHC II expressing cells we were able to observe antigen presenting cells, which are essential for the onset of immune responses, in their natural environment. Thus, we report some original features of the immune system. We have identified MHC II+ cell clusters with unknown, probably unique function, in the intestine. We have also described MHC II+ cell migration to the lactating mammary gland and tested few hypotheses about the role of this phenomenon for the development of the mammary gland, milk secretion or infant immune system establishment. Lastly, we observed residential macrophages in the cornea. The presence of APCs in the cornea is a very contradictory issue due to the fact that cornea is an immunologically privileged tissue and therefore harbors special immune features. key words: antigen presenting cells (APC), major histocompatibility complex class II (MHC II), enhanced green fluorescent protein (EGFP), immune system, knock-in mouse model